Skip to main content
. Author manuscript; available in PMC: 2013 Jun 25.
Published in final edited form as: Basic Res Cardiol. 2009 May 13;104(6):681–693. doi: 10.1007/s00395-009-0033-3

Fig. 3.

Fig. 3

Changes in sympathetic innervation after clodronate liposome treatment are reflected by multiple markers. Adjacent sections from hearts receiving coronary artery ligation plus saline (C+S) or ligation plus clodronate liposomes (C+C) were immunostained for DBH, which characterizes noradrenergic neurons (a, d), the intermediate filament protein peripherin which stains intact unmyelinated axons (b, e), and tyrosine hydroxylase that is a marker for catecholaminergic axons (c, f). Levels of innervation density were comparable under different treatments with all markers. Scale bar 10 μm